BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8693488)

  • 1. Role of atrial natriuretic peptide in interleukin 1 beta-induced natriuresis in conscious rats.
    Funyu T; Kimura T; Yamamoto T; Ota K; Shoji M; Ohta M; Sato K; Abe K
    Tohoku J Exp Med; 1995 Sep; 177(1):73-87. PubMed ID: 8693488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of GABA in the central regulation of AVP and ANP release and blood pressure due to angiotensin and carbachol, and central GABA release due to blood pressure changes.
    Kimura T; Funyu T; Ohta M; Yamamoto T; Ota K; Shoji M; Inoue M; Sato K; Abe K
    J Auton Nerv Syst; 1994 Dec; 50(1):21-9. PubMed ID: 7844311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of GABA in the central regulation of AVP and ANP release and blood pressure in hypertonic saline infusion and hemorrhage.
    Kimura T; Yamamoto T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Funyu T; Abe K
    J Auton Nerv Syst; 1993 May; 43(2):171-8. PubMed ID: 8326097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a nitric oxide synthase inhibitor on vasopressin and atrial natriuretic hormone release, thermogenesis and cardiovascular functions in response to interleukin-1 beta in rats.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Funyu T; Abe K
    Tohoku J Exp Med; 1994 Sep; 174(1):59-69. PubMed ID: 7532327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats.
    Gutkowska J; Jankowski M; Mukaddam-Daher S; McCann SM
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):483-8. PubMed ID: 10618444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interleukin-1 beta on blood pressure, thermoregulation, and the release of vasopressin, ACTH and atrial natriuretic hormone.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Funyu T; Abe K
    Tohoku J Exp Med; 1994 Jun; 173(2):231-45. PubMed ID: 7817387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide.
    Kimura T; Yamamoto T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Funyu T; Yoshinaga K
    Ann N Y Acad Sci; 1993 Jul; 689():330-45. PubMed ID: 8396869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
    Ota K; Kimura T; Inoue M; Funyu T; Shoji M; Sato K; Ohta M; Yamamoto T; Abe K
    Eur J Endocrinol; 1995 Jul; 133(1):127-32. PubMed ID: 7627334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasopressin on atrial natriuretic peptide release and renal function in dogs.
    Inoue M; Kimura T; Ota K; Iitake K; Shoji M; Sato K; Ota M; Yoshinaga K
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E449-55. PubMed ID: 2972212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin on cardiovascular and renal functions and ANP release under plasma volume expansion.
    Ohta M; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Yamamoto T; Yoshinaga K
    Tohoku J Exp Med; 1991 Oct; 165(2):115-29. PubMed ID: 1839872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vagal nerves and atrial natriuretic hormone in vasopressin release and a diuresis under hypertonic volume expansion.
    Sato K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Yamamoto T; Funyu T; Yoshinaga K; Abe K
    Acta Endocrinol (Copenh); 1993 Jul; 129(1):65-74. PubMed ID: 7688922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of atrial natriuretic peptide, vasopressin, aldosterone and renal function to intracerebroventricular infusion of angiotensin II in dogs.
    Shoji M; Kimura T; Ota K; Inoue M; Sato K; Ohta M; Yamamoto T; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1991 Mar; 163(3):187-97. PubMed ID: 1829554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
    Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
    Hansell P; Fasching A; Sjöquist M; Andén NE; Ulfendahl HR
    Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide attenuates pressor but enhances natriuretic responses to angiotensin II in pregnant conscious goats.
    Olsson K; Hossaini-Hilali J; Eriksson L
    Acta Physiol Scand; 1992 Aug; 145(4):385-94. PubMed ID: 1388314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
    Abu-Amarah I; Balment RJ
    Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine vasopressin-induced natriuresis in the anaesthetized rat: involvement of V1 and V2 receptors.
    Smith CP; Balment RJ
    J Endocrinol; 1993 Feb; 136(2):283-8. PubMed ID: 8459193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.